Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic oral low-dose cyclophosphamide + dexamethasone in hormone-refractory prostate carcinoma
2004-004448-30Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide and dexamethasone in prostate cancer (PCa), sponsored by Policlinico Gemelli. Started Nov 2007; status: completed.
02
Drugs
cyclophosphamidedexamethasone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2004-004448-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004448-30.